Article 726
Investigator-initiated trials see dramatic drop
Regulatory scrutiny thwarting innovation, cost-effectiveness
Article 727
Sponsors seeking preferred relationships with best sites
As many rethink popular over-recruitment strategy
Article 728
Allergan
Allergan is a $4.8 billion, multi-specialty healthcare company identifying itself as “global in reach, specialized in focus.” It employs about 10,000 worldwide and maintains a presence in more than 100 countries. By collaborating with medical specialists who provide their perspectives on unmet patient needs, Allergan aims to discover, develop and market innovative pharmaceuticals, biologics, medical devices and over-the-counter consumer products “that enable people to live life to its greatest potential.”